Alibaba Competitors

Pink Sheets . USA . 
Stock . Alibaba Health Information
ALBBY Stock  USD 9.74  0.13  1.35%   
Alibaba Health Infor competes with Walgreens Boots, Alibaba Health, PetMed Express, High Tide, and China Jo; as well as few others. The company classifies itself under Healthcare sector and is part of Pharmaceutical Retailers industry. Analyzing Alibaba Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Alibaba Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Alibaba Health Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Alibaba Health competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
3.359.7416.13
Details
Intrinsic
Valuation
LowRealHigh
2.468.8515.24
Details
Naive
Forecast
LowNextHigh
2.078.4614.85
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.3710.4711.57
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Alibaba Health. Your research has to be compared to or analyzed against Alibaba Health's peers to derive any actionable benefits. When done correctly, Alibaba Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Alibaba Health Infor.

Alibaba Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Alibaba Health and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Alibaba and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Alibaba Health Infor does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
CJJD
+ 0.68
ALBHF
HITI
+ 0.68
PETS
CJJD
+ 0.64
HITI
CJJD
+ 0.55
PETS
PETS
+ 0.53
ALBHF
HITI
+ 0.4
ALBHF
  
High negative correlations   
PETS
- 0.78
RAD
HITI
- 0.75
RAD
CJJD
- 0.73
RAD
RAD
- 0.51
ALBHF
HITI
- 0.29
AEGY
PETS
- 0.28
AEGY

Risk-Adjusted Indicators

There is a big difference between Alibaba Pink Sheet performing well and Alibaba Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Alibaba Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
All Fundamental Data

Alibaba Health Competitive Analysis

The better you understand Alibaba Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Alibaba Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Alibaba Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ALBBY AEGY ALST WBA ALBHF DECN RAD PETS HITI CJJD
 1.35 
 9.74 
Alibaba
 0.00 
 0.0001 
Alternative
 20.00 
 0.0006 
Allstar
 4.34 
 8.66 
Walgreens
 9.43 
 0.48 
Alibaba
 0.00 
 0.0001 
Decision
 2.50 
 1.56 
Rite
 3.02 
 4.78 
PetMed
 0.75 
 2.65 
High
 1.01 
 2.00 
China
Market Volatility
(90 Days Market Risk)
Moderately volatile
Out of control
Out of control
Slightly risky
Out of control
Very steady
Very steady
Unstable
Unstable
Extremely Dangerous
Market Performance
(90 Days Performance)
Modest
OK
Insignificant
Very Weak
OK
Very Weak
Very Weak
OK
Good
Modest
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Quite High
Below Average
Low
Very High
Dangerous
Low
Below Average
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Hold
Not Available
Not Available
Not Available
Hold
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Not Rated
Strong Hold
Strong Sell
Strong Sell
Current Ratio
2.81
0.24
0.03
0.75
2.81
0.25
1.33
5.61
1.23
1.01
Net Asset
19.2 B
N/A
15.53 K
81.04 B
19.2 B
5.65 M
7.53 B
169.88 M
233.4 M
95.06 M
Profit Margin
0.0056
N/A
N/A
-0.0585
0.0056
N/A
-0.0399
-0.0037
-0.0596
-0.0274
EBITDA
(248.7 M)
N/A
(2 M)
(11.28 B)
(248.7 M)
(2.41 M)
178.44 M
(394 K)
(4.2 M)
1.23 M
Operating Margin
-0.0236
N/A
-44.09
0.0235
-0.0236
-0.95
4.0E-4
0.0144
0.0341
-0.0499
Current Valuation
14.83 B
155.59 K
N/A
36.92 B
14.83 B
3.06 M
6.08 B
43.82 M
235.98 M
35.3 M
Price To Book
8.08
N/A
N/A
0.69
7.69
2.72
3.77
0.98
2.07
0.78
Current Asset
N/A
163 K
N/A
25.88 B
N/A
4.3 M
4.55 B
67.63 M
N/A
46.88 M
Retained Earnings
N/A
N/A
N/A
23.35 B
N/A
(79.4 M)
(6.6 B)
71.56 M
(205.93 M)
(73.51 M)
Five Year Return
N/A
N/A
N/A
3.54
N/A
N/A
1.94
3.99
N/A
N/A
Beta
0.98
-58.2
-0.96
0.67
0.98
-1.78
1.29
0.68
1.0
-0.043
Number Of Employees
1.58 K
N/A
4
193 K
1.58 K
6
47 K
287
1.55 K
939
Shares Outstanding
676.01 M
4.11 B
N/A
864.62 M
13.52 B
357.87 M
56.7 M
20.66 M
80.68 M
6.18 M
Cash Flow From Operations
424.36 M
(47.34 K)
(60.57 K)
1.02 B
424.36 M
(1.4 M)
(52.44 M)
4.32 M
20.66 M
(3.16 M)
Annual Yield
N/A
N/A
N/A
0.12
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
135.41 M
383.06 K
2.88 M
32.85 B
135.41 M
2.93 M
5.82 B
1.45 M
72.53 M
43.22 M
Return On Equity
0.0088
N/A
N/A
-0.76
0.0088
-81.61
-26.29
-0.0092
-0.2
-0.27
Z Score
49.6
N/A
N/A
N/A
47.2
N/A
2.14
N/A
N/A
N/A
Return On Asset
-0.0168
-2.55
N/A
0.0059
-0.0168
-0.21
8.0E-4
-9.0E-4
0.0315
-0.0238
Book Value Per Share
22.12
N/A
N/A
12.09
1.11
N/A
-17.16
4.67
1.8
8.97
Number Of Shares Shorted
N/A
N/A
N/A
87.43 M
N/A
N/A
18.07 M
1.7 M
4.24 M
43.79 K
Current Liabilities
N/A
671 K
N/A
17.01 B
N/A
3.06 M
3 B
7.08 M
N/A
42.12 M
Total Asset
19.2 B
N/A
15.53 K
81.04 B
19.2 B
5.65 M
7.53 B
169.88 M
233.4 M
95.06 M
Debt To Equity
0.009
N/A
N/A
1.2
0.009
9.05
N/A
N/A
0.31
2.14
Short Ratio
N/A
N/A
N/A
3.59
N/A
N/A
2.68
9.34
5.6
1.3
Target Price
N/A
N/A
N/A
10.81
N/A
N/A
1.0
3.75
4.5
7.0
Last Dividend Paid
N/A
N/A
N/A
1.23
N/A
N/A
N/A
0.3
N/A
N/A
Shares Owned By Institutions
N/A
N/A
2.3
61.59
10.9
N/A
49.33
47.86
10.17
0.31
Market Capitalization
11.01 B
411.18 K
165.83 M
7.18 B
10.49 B
35.79 K
36.76 M
95.88 M
215.41 M
12.23 M
Price To Earning
210.12
N/A
N/A
8.1
232.77
-0.33
0.86
12.75
N/A
-4.6
Price To Earnings To Growth
N/A
N/A
N/A
3.55
N/A
N/A
0.87
2.58
N/A
N/A
Price To Sales
0.66
N/A
4026.27
0.0486
0.61
0.0168
0.0099
0.37
0.42
0.0792
Net Income
(265.56 M)
(3.62 M)
(7.09 M)
(15.45 B)
(265.56 M)
(29.67 M)
(749.94 M)
(7.46 M)
(40.95 M)
(4.23 M)
Earnings Per Share
0.03
N/A
N/A
-10.01
N/A
-0.02
-14.34
-0.06
-0.29
-2.93
Shares Owned By Insiders
N/A
N/A
N/A
17.66
64.61
N/A
2.66
8.1
8.8
38.34
Revenue
20.58 B
N/A
33.87 K
147.66 B
20.58 B
1.98 M
24.09 B
281.06 M
487.67 M
154.54 M
Working Capital
N/A
(508 K)
N/A
(8.62 B)
N/A
(3.3 M)
573.17 M
21.49 M
10.51 M
(4.68 M)
Cash And Equivalents
10.55 B
155.11 K
N/A
2.48 B
10.55 B
210.85 K
157.15 M
105.41 M
18.74 M
18.55 M
Cash Per Share
15.64
N/A
N/A
2.87
0.78
N/A
0.83
5.21
0.27
5.33
Gross Profit
4.11 B
N/A
(95.76 K)
27.07 B
4.11 B
194.17 K
4.8 B
78.08 M
100.95 M
34.28 M
Day Typical Price
9.74
1.0E-4
6.0E-4
8.52
0.48
1.0E-4
1.58
4.76
2.65
2.02
Accumulation Distribution
N/A
N/A
N/A
1.1 M
N/A
N/A
0.037
6267.44
17144.77
33.99
Market Facilitation Index
N/A
N/A
N/A
N/A
N/A
N/A
0.06
0.0
N/A
1.0E-4
Daily Balance Of Power
9.2 T
0.0
9.2 T
0.75
(9,223,372,036,855)
0.0
(0.67)
0.6667
(0.22)
0.2857
Period Momentum Indicator
0.13
N/A
1.0E-4
0.36
(0.05)
N/A
(0.04)
0.14
(0.02)
0.02
Rate Of Daily Change
1.01
1.0
1.2
1.04
0.91
1.0
0.98
1.03
0.99
1.01
Day Median Price
9.74
1.0E-4
6.0E-4
8.45
0.48
1.0E-4
1.59
4.74
2.65
2.04
Price Action Indicator
0.065
N/A
1.0E-4
0.39
(0.03)
N/A
(0.05)
0.11
(0.01)
(0.03)
Coefficient Of Variation
1175.45
1038.68
5974.61
(1,459)
1044.74
N/A
(703.85)
777.96
665.07
1775.36
Mean Deviation
3.38
11.97
3.64
2.36
4.92
N/A
2.96
2.83
2.63
5.25
Jensen Alpha
0.591
6.47
0.0217
(0.29)
1.03
N/A
(0.71)
0.6071
0.5153
0.4437
Total Risk Alpha
(0.30)
(1.73)
(1.00)
(0.70)
(0.29)
N/A
(1.08)
(0.02)
0.0564
(0.55)
Sortino Ratio
0.0573
N/A
0.0017
N/A
0.073
N/A
N/A
0.1718
0.1334
0.0494
Downside Variance
55.27
N/A
456.7
N/A
83.43
N/A
N/A
11.31
8.6
37.22
Standard Deviation
6.29
50.36
8.73
3.45
8.11
N/A
3.91
5.35
3.33
7.29
Kurtosis
8.24
60.95
5.53
6.51
3.89
N/A
0.6039
28.61
0.961
2.9
Potential Upside
10.3
N/A
16.67
5.22
15.0
N/A
6.16
6.17
6.27
10.96
Treynor Ratio
(0.79)
(0.30)
0.1184
(0.59)
(0.29)
N/A
(0.40)
0.9613
(1.99)
(0.93)
Maximum Drawdown
47.35
480.0
50.0
22.71
51.23
N/A
20.18
43.08
18.6
38.42
Variance
39.59
2536.13
76.2
11.92
65.77
N/A
15.29
28.58
11.09
53.16
Market Risk Adjusted Performance
(0.78)
(0.29)
0.1284
(0.58)
(0.28)
N/A
(0.39)
0.9713
(1.98)
(0.92)
Risk Adjusted Performance
0.0737
0.0833
0.0219
(0.04)
0.0821
N/A
(0.10)
0.1066
0.1224
0.0519
Skewness
1.62
7.59
0.2786
1.42
0.9833
N/A
(0.12)
4.36
0.0477
1.18
Semi Deviation
3.86
N/A
6.21
N/A
5.42
N/A
N/A
2.74
2.66
5.7
Information Ratio
0.0677
0.0941
0.0042
(0.10)
0.0822
N/A
(0.17)
0.1081
0.1175
0.0413
Value At Risk
(7.68)
N/A
(14.29)
(4.07)
(13.16)
N/A
(6.88)
(4.89)
(3.52)
(8.87)
Expected Short fall
(7.98)
N/A
(20.16)
N/A
(9.80)
N/A
N/A
(3.24)
(3.04)
(6.18)
Downside Deviation
7.43
N/A
21.37
N/A
9.13
N/A
N/A
3.36
2.93
6.1
Semi Variance
14.93
N/A
38.56
N/A
29.39
N/A
N/A
7.51
7.09
32.54

Alibaba Health Competition Performance Charts

Five steps to successful analysis of Alibaba Health Competition

Alibaba Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Alibaba Health Infor in relation to its competition. Alibaba Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Alibaba Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Alibaba Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Alibaba Health Infor, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Alibaba Health position

In addition to having Alibaba Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials ETFs Thematic Idea Now

Financials ETFs
Financials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Alibaba Pink Sheet Analysis

When running Alibaba Health's price analysis, check to measure Alibaba Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alibaba Health is operating at the current time. Most of Alibaba Health's value examination focuses on studying past and present price action to predict the probability of Alibaba Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alibaba Health's price. Additionally, you may evaluate how the addition of Alibaba Health to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY